(Corrects date in paragraph 2 to April 22 from Aug. 22)
May 12 U.S. medical firm Allergan Inc
rejected the unsolicited takeover offer from Valeant
Pharmaceuticals International Inc , saying it
substantially undervalued the company.
Canada's Valeant said on April 22 that it and activist
investor Bill Ackman made an unsolicited $47 billion bid to buy
Allergan, which makes the popular anti-wrinkle treatment
Botox, also said on Monday it expected to increase its earnings
per share by 20-25 percent and continue to generate double digit
revenue growth in 2015.
(Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)